A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy von Myette, James R., Kano, Toshiki, Suzuki, Hitoshi, Sloan, Susan E., Szretter, Kristy J., Ramakrishnan, Boopathy, Adari, Hedy, Deotale, Ketan D., Engler, Frank, Shriver, Zachary, Wollacott, Andrew M., Suzuki, Yusuke, Pereira, Brian J.G.

Volltext

An Immune Based, Anti-CD138 Targeting Antibody for the Treatment of Multiple Myeloma von Yu, Tengteng, Xing, Lijie, Lin, Liang, Liu, Jiye, Wen, Kenneth, Cho, Shih-Feng, Hsieh, Phillip, Myette, James, Chaganty, Bharat, Adari, Hedy, Tissire, Hamid, Deotale, Ketan, Shriver, Zach, Munshi, Nikhil, Tai, Yu-Tzu, Anderson, Kenneth

Volltext

Abstract 376: CRLX101, a nanopharmaceutical in phase 2 clinical trials, is synergistic with antiangiogenic treatment through HIF-1α inhibition in an ovarian cancer xenograft model von Lazarus, Douglas, Peters, Christian, Deotale, Ketan, Eliasof, Scott

Volltext

Optimized hybrid RNN model for human activity recognition in untrimmed video von Deotale, Disha, Verma, Madhushi, Suresh, Perumbure, Kotecha, Ketan

Volltext